A review published in the 2026 issue of *Nutrients* analyses how dietary polyphenols modulate the central nervous system to mitigate the neurological complications associated with obesity. The authors, Han T, Wei L and colleagues, summarise the available evidence on the bidirectional interaction between obesity and the brain, with particular attention to the role of compounds such as EGCG from green tea in regulating appetite, central neuroinflammation and cognitive function.
The review was not conducted in healthy adults, but rather in the context of the metabolic and neurological complications of obesity. Its findings are relevant to understanding the biological mechanisms linking excess body fat to cognitive impairment, leptin resistance and hypothalamic inflammation.
How obesity alters brain structure and function according to current evidence
Obesity exerts negative effects on the brain through several simultaneous mechanisms. Excessive lipid accumulation activates immune cells that elevate pro-inflammatory cytokines such as TNF-α, IL-1β and IL-6. These molecules can cross a compromised blood-brain barrier and disrupt neurotransmitter transmission, synaptic plasticity and neuroendocrine signalling.
The studies included in the review show that individuals with obesity have reduced grey matter volume in regions involved in cognitive control and emotional regulation. Furthermore, central insulin and leptin resistance, which are common in obesity, impair the pathways that regulate appetite and energy metabolism, creating a cycle that exacerbates the complications themselves.
The role of EGCG from green tea in central neuroinflammation in models of obesity
EGCG, the main polyphenol in green tea, is one of the most extensively studied compounds in this context. The review provides evidence that EGCG can cross the blood-brain barrier and reach the brain parenchyma. In animal models of obesity induced by a high-fat diet, EGCG supplementation suppressed the phosphorylation of key proteins in the NF-κB and JAK2/STAT3 pathways in the hypothalamus, leading to a reduction in pro-inflammatory cytokines such as TNF-α, IL-6 and IL-1β.
Further data indicate that EGCG modulated the expression of appetite-regulating genes in the hypothalamus, including Agrp, Pomc and Cart, and altered the circadian oscillation patterns of these genes in diet-induced obese mice. The review also notes that human studies with small sample sizes found that acute supplementation with 752 mg of EGCG delayed gastric emptying and improved satiety, although the authors caution that larger-scale studies are needed to confirm these effects.
The gut-brain axis and dietary polyphenols in the regulation of energy balance
The review devotes a significant section to the gut-brain axis as a key communication pathway between the microbiota, microbial metabolites and the central nervous system. Obesity-associated gut dysbiosis alters the secretion of hormones such as GLP-1 and PYY, which signal to the brain to regulate food intake. Short-chain fatty acids produced by the microbial fermentation of dietary fibre also play a role in this regulation, modulating the activity of orexigenic neurons in the hypothalamus and brainstem.
Polyphenols can favourably modulate the composition of the microbiota and the production of these metabolites. The evidence presented suggests that this mechanism represents an additional pathway through which dietary polyphenolic compounds help to mitigate the neurological complications of obesity, although the authors acknowledge that much of the evidence comes from animal models.
Why effective doses of polyphenols are difficult to achieve through a normal diet alone
The review explicitly points out that some of the doses used in animal studies are equivalent to very high quantities of green tea for a human consumer. For example, supplementation with 1% EGCG in mice would correspond to approximately 15.6 cups of green tea per day in humans, a quantity clearly beyond normal consumption. The dose of 255 mg/kg/day, equivalent to around 5 cups a day, is more achievable but remains difficult to maintain consistently through diet alone.
This finding highlights a significant practical gap. Polyphenol-rich foods provide these compounds in varying concentrations, and their bioavailability is influenced by the food matrix, processing methods and individual habits. Consistency in the daily intake of specific compounds such as EGCG is difficult to guarantee through diet alone.
How Minfire by Nutribiolite, a caffeine-free nootropic dietary supplement, applies the physiological logic of the study
The study analyses the role of dietary polyphenols, with a particular focus on EGCG from green tea, on the brain mechanisms affected by obesity. Minfire contains a green tea leaf extract (Camellia sinensis L. Kuntze) standardised to 95% polyphenols, 80% catechins and 50% EGCG, which ensures a precise and consistent intake of the main compound analysed in the review.
This standardised concentration ensures that each capsule contains a controlled amount of EGCG, unlike drinking green tea as an infusion, where the concentration varies considerably depending on steeping time, temperature and the variety of tea leaf. Minfire contains no unnecessary additives, artificial colourings, preservatives, added sugars, gluten or lactose.
The formula is complemented by bacopa extract (Bacopa monnieri, standardised to 50% bacosides), ginkgo biloba extract (24% flavonoid glycosides and 6% terpene lactones), lion’s mane extract (Hericium erinaceus, 30% polysaccharides), L-tyrosine, highly bioavailable choline L-bitartrate and plant-based phosphatidylserine derived from soya lecithin. These neuroactive nutrients provide precursors for key neurotransmitters such as acetylcholine, dopamine and noradrenaline, and help maintain the integrity of neuronal membranes.
Minfire is a caffeine-free nootropic, formulated for those seeking a daily intake of phytonutrients and neuroactive nutrients without excessive stimulation or changes to heart rate.

Minfire combines green tea extract standardised to 50% EGCG, bacopa standardised to 50% bacosides, ginkgo biloba, lion’s mane, L-tyrosine, choline and plant-based phosphatidylserine in a caffeine-free nootropic formula with no unnecessary additives.
Frequently asked questions about polyphenols, obesity and cognitive function
What are dietary polyphenols and why are they relevant in the context of obesity?
Polyphenols are secondary plant metabolites found in tea, fruit, vegetables, coffee and wine. A review published in *Nutrients* in 2026 identifies them as compounds capable of modulating the brain via multiple pathways, including the regulation of appetite, central neuroinflammation, and the insulin and leptin resistance associated with obesity. Their neuroregulatory potential makes them the subject of growing interest in nutraceutical research.
What role does EGCG from green tea play in the brain, according to the studies included in this review?
EGCG is the most abundant polyphenol in green tea. The review presents evidence from animal studies showing that EGCG can cross the blood-brain barrier, suppress pro-inflammatory pathways such as NF-κB and JAK2/STAT3 in the hypothalamus, and modulate appetite-regulating genes. Two small-scale human studies observed effects on gastric emptying and satiety, although the authors themselves note that larger-scale research is needed to confirm these results in humans.
Does obesity directly affect cognitive function?
According to the review, epidemiological evidence shows that abdominal obesity is associated with an increased risk of cognitive decline. Proposed mechanisms include chronic neuroinflammation, central insulin and leptin resistance, oxidative stress and alterations in the gut-brain axis. These factors act synergistically and may compromise synaptic plasticity, grey matter volume and the expression of BDNF, a factor involved in neuronal survival.
Why is it difficult to obtain effective doses of EGCG from green tea consumption alone?
The review notes that some doses used in animal studies would be equivalent to between 5 and 15 cups of green tea per day in humans. The actual concentration of EGCG in an infusion varies depending on the type of leaf, the temperature and the brewing time. A standardised extract ensures a precise and consistent intake of these compounds, something that is difficult to achieve through regular tea consumption.
Is Minfire suitable for people with obesity or metabolic complications?
Minfire is a nootropic food supplement formulated to support mental performance and cognitive function as part of a balanced diet and a healthy lifestyle. It is not designed to treat, prevent or cure obesity or any of its complications. The reference study was conducted in the context of obesity-related complications, not in healthy adults in general. If you have any health conditions, please consult a healthcare professional.
This content is for information purposes only and is not a substitute for advice from a healthcare professional.









